December 21, 2025 a 06:00 pm
PODD: Fundamental Ratio Analysis - Insulet Corporation
Insulet Corporation is a notable player in the medical devices sector, focusing on innovative insulin delivery systems. With its wireless Omnipod System, the company addresses the chronic needs of diabetes patients, offering a convenient and effective solution for glucose management. The stock reflects a mix of stability and growth potential, particularly within its target demographic markets.
Fundamental Rating
The fundamental analysis of Insulet Corporation highlights its strengths and weaknesses through various key financial ratios.
| Category | Score | Visualization |
|---|---|---|
| Overall Score | 3 | |
| Discounted Cash Flow (DCF) | 1 | |
| Return on Equity (ROE) | 5 | |
| Return on Assets (ROA) | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The historical performance of key financial metrics helps in understanding the trend of Insulet Corporation's financial health.
| Date | Overall | DCF | ROE | ROA | Debt To Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | 3 | 1 | 5 | 5 | 3 | 1 | 1 |
| Not Available | 0 | 1 | 5 | 5 | 3 | 1 | 1 |
Analyst Price Targets
Analyst price targets provide insight into the potential stock price movement in the near future.
| High | Low | Median | Consensus |
|---|---|---|---|
| $450 | $301 | $385 | $383.88 |
Analyst Sentiment
The consensus among analysts provides a useful perspective on insider opinions regarding the stock.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 31 | |
| Hold | 12 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
Insulet Corporation exhibits strong potential within the healthcare sector, backed by its innovative product offerings. The company's strengths in return metrics are buoyed by its strategic presence in various international markets. However, the relatively weak performance in discounted cash flow and valuation ratios may pose risks. Analysts maintain a generally positive outlook, reflected in a consensus price target that suggests a modest upside. Investors should weigh these factors carefully within the context of an ever-evolving industry landscape.